Literature DB >> 2493489

Acute phase response in cerebral infarction.

J Syrjänen1, A M Teppo, V V Valtonen, M Iivanainen, C P Maury.   

Abstract

The serum concentrations of the acute phase proteins, C-reactive protein, serum amyloid A protein, and alpha-1-antichymotrypsin were determined in 50 young and middle aged patients with cerebral infarction and in sex and age matched community controls. Of 46 case control pairs, 11 cases but only one control had raised acute phase protein concentrations simultaneously (p less than 0.01); four case control pairs were excluded because of an infectious complication following infarction and an acute phase response. Seven of the 11 patients (64%) with raised acute phase protein concentrations had a history of bacterial infection in the preceding month but of the remaining 35 patients without raised concentrations only four (11%) had such a history (p less than 0.01). In general, the acute phase response was less pronounced and occurred less often than has been reported in patients after acute myocardial infarction. The results suggest that a positive acute phase response is associated with a preceding bacterial infection or with an infectious complication after cerebral infarction. Measurement of acute phase proteins, therefore, could be used to evaluate the possible role of preceding bacterial infection in the development of cerebral infarction and also in the management of these patients as an early indicator of possible infectious complications.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493489      PMCID: PMC1141793          DOI: 10.1136/jcp.42.1.63

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Platelet agonist synergism by the acute phase reactant C-reactive protein.

Authors:  B A Fiedel
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

2.  New year message.

Authors:  T Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

Review 3.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

4.  Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia.

Authors:  P L McCarthy; A L Frank; R C Ablow; S J Masters; T F Dolan
Journal:  J Pediatr       Date:  1978-03       Impact factor: 4.406

5.  C-reactive protein for rapid monitoring of infections of the central nervous system.

Authors:  H O Peltola
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

6.  Serum amyloid A protein in acute myocardial infarction.

Authors:  G Marhaug; L Hårklau; B Olsen; G Husby; A Husebekk; H Wang
Journal:  Acta Med Scand       Date:  1986

7.  The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods.

Authors:  Y Kerttula; M Leinonen; M Koskela; P H Mäkelä
Journal:  J Infect       Date:  1987-01       Impact factor: 6.072

8.  Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection.

Authors:  C P Maury; A M Teppo
Journal:  Clin Nephrol       Date:  1984-12       Impact factor: 0.975

9.  Comparative study of serum amyloid A protein and C-reactive protein in disease.

Authors:  C P Maury
Journal:  Clin Sci (Lond)       Date:  1985-02       Impact factor: 6.124

10.  Acute-phase proteins from the liver and enzymes from myocardial infarction; a quantitative relationship.

Authors:  S J Smith; G Bos; M R Esseveld; H G Van Eijk; J Gerbrandy
Journal:  Clin Chim Acta       Date:  1977-11-15       Impact factor: 3.786

View more
  5 in total

1.  Risk factors for intracardiac thrombus in patients with recent ischaemic cerebrovascular events.

Authors:  S Sen; S Laowatana; J Lima; S M Oppenheimer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

2.  Protein-energy malnutrition increases activation of the transcription factor, nuclear factor kappaB, in the gerbil hippocampus following global ischemia.

Authors:  Liang Ji; Adil J Nazarali; Phyllis G Paterson
Journal:  J Nutr Biochem       Date:  2008-04-21       Impact factor: 6.048

Review 3.  Inflammation in acute ischemic stroke and its relevance to stroke critical care.

Authors:  Hedley C A Emsley; Craig J Smith; Pippa J Tyrrell; Stephen J Hopkins
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

4.  Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study.

Authors:  L Azurmendi; V Lapierre-Fetaud; J Schneider; J Montaner; M Katan; Jean-Charles Sanchez
Journal:  Clin Proteomics       Date:  2017-07-12       Impact factor: 3.988

5.  Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor.

Authors:  Katarzyna Śmiłowska; Marek Śmiłowski; Robert Partyka; Danuta Kokocińska; Przemysław Jałowiecki
Journal:  J Pers Med       Date:  2022-03-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.